Netherlands· NL-7326d6640fb0

Olbetam, capsules 250 mg

A acipimox product containing acipimox, registered in Netherlands by Pfizer B.V.. The same ATC class is registered in 6 of our 19 countries.

ATC C10AD06

Checked against CBG-MEB (Netherlands) on September 29, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about acipimoxAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Acipimox is registered in 6 of 19 countries.

Countries holding a registration under ATC C10AD06 (acipimox), each read from that country’s own register.

This record: Netherlands, from CBG-MEB (Netherlands)
3 of them publish a price we can compare per daily dose

Search acipimox products by name

Acipimox · ATC C10AD06

6 / 19 countries

Belgiumprice
Denmark
Finlandprice
Netherlands
Norwayprice
United Kingdom

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)

Active substance: ACIPIMOX
Manufacturer: Pfizer B.V.
Country: Netherlands (NL)
ATC code: C10AD06
ATC class: Acipimox
Defined daily dose: 0.5 g, O
Reimbursed: Not published by this register
Source register: CBG-MEB (Netherlands)
Last checked: September 29, 2026

Packs & prices · 1

cbg_meb_id
13159

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Acipimox in 4 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All acipimox products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

Denmark · Olbetam
United Kingdom (Northern Ireland) · Olbetam
Italy · Olbetam

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/61b9cb50-e2e3-4593-8db7-f763077b94f2
GET /v1/drugs/61b9cb50-e2e3-4593-8db7-f763077b94f2?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Capsule, hard",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h13159_smpc.pdf",
  "strength": null,
  "atc_label": "Acipimox",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg13159",
  "excipients": [
    "GELATINE (E 441)",
    "IJZEROXIDE GEEL (E 172)",
    "IJZEROXIDE ROOD  (E 172)",
    "MAGNESIUMSTEARAAT (E 470b)",
    "MAÏSZETMEEL, GEPREGELATINEERD",
    "NATRIUMLAURILSULFAAT",
    "SILICIUMDIOXIDE (E 551)",
    "TITAANDIOXIDE (E 171)"
  ],
  "substances": [
    "ACIPIMOX"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h13159.pdf",
  "authorised_at": "1990/12/14",
  "procedure_number": null,
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "13159",
  "additional_monitoring": "N"
}

API reference MCP server Plans

See everything about acipimox.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console